Scientific work

Prof. Dr. Yaşar Çolak

74 publications. The source of the information is stated next to each publication.

Back to profile

  1. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores.

    PubMed, 2012

    PMID 23042372 29 citations (Europe PMC) Source: OpenAlex

  2. Nonalcoholic Fatty Liver Disease: A Nutritional Approach

    Metabolic Syndrome and Related Disorders, 2012

    DOI 10.1089/met.2011.0145 PMID 22394108 19 citations (Europe PMC) Source: OpenAlex

  3. Concentrations of Connective Tissue Growth Factor in Patients with Nonalcoholic Fatty Liver Disease: Association with Liver Fibrosis

    Disease Markers, 2012

    DOI 10.1155/2012/283726 PMID 22846210 14 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

    Digestive and Liver Disease, 2012

    DOI 10.1016/j.dld.2012.08.017 PMID 22995553 23 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease

    Scandinavian Journal of Gastroenterology, 2012

    DOI 10.3109/00365521.2012.725093 PMID 23137022 18 citations (Europe PMC) Source: OpenAlex

  6. Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans

    Gastroenterology Research and Practice, 2012

    DOI 10.1155/2012/159438 PMID 22611378 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. The effect of HLA-DQB1 alleles on virologic breakthroughs during chronic hepatitis B treatment with genetically low barrier drugs

    Clinics and Research in Hepatology and Gastroenterology, 2012

    DOI 10.1016/j.clinre.2012.10.013 PMID 23273495 5 citations (Europe PMC) Source: OpenAlex

  8. Sa1242 Serum Anti-MüLlerian Hormone Levels are Lower in Reproductive-Age Women With Crohn's Disease Compared to Healthy Control Women

    Gastroenterology, 2012

    DOI 10.1016/s0016-5085(12)60949-4 Source: OpenAlex

  9. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease

    Medical Science Monitor, 2011

    DOI 10.12659/msm.881749 PMID 21525818 120 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. Serum Levels of Hepcidin in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease

    Metabolic Syndrome and Related Disorders, 2011

    DOI 10.1089/met.2010.0121 PMID 21417913 44 citations (Europe PMC) Open-access full textSource: OpenAlex

  11. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease

    European Journal of Gastroenterology & Hepatology, 2011

    DOI 10.1097/meg.0b013e32834e8041 PMID 22157234 35 citations (Europe PMC) Source: OpenAlex

  12. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome

    European Journal of Clinical Investigation, 2011

    DOI 10.1111/j.1365-2362.2011.02597.x PMID 21913918 28 citations (Europe PMC) Source: OpenAlex

  13. Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis

    Clinica Chimica Acta, 2011

    DOI 10.1016/j.cca.2011.08.025 PMID 21888902 17 citations (Europe PMC) Source: OpenAlex

  14. Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease

    Metabolic Syndrome and Related Disorders, 2011

    DOI 10.1089/met.2011.0111 PMID 22112193 20 citations (Europe PMC) Source: OpenAlex

  15. Characterization of Nonalcoholic Fatty Liver Disease Unrelated to the Metabolic Syndrome

    Gastroenterology, 2011

    DOI 10.1016/s0016-5085(11)64095-x Source: OpenAlex

  16. Plasma Fibrinogen-Like Protein 2 Levels in Patients with Non-Alcoholic Fatty Liver Disease

    Hepatogastroenterology, 2011

    DOI 10.5754/hge11248 PMID 22024080 15 citations (Europe PMC) Source: OpenAlex

  17. Ecstasy induced fatal hepatic failure.

    PubMed, 2011

    PMID 21725523 2 citations (Europe PMC) Source: OpenAlex

  18. Is the Lymphoma Risk Reduced in Viral Hepatitis? A Cirrhotic Patient With Triple Malignancies

    The American Journal of Gastroenterology, 2011

    DOI 10.1038/ajg.2011.214 PMID 21897412 Source: OpenAlex

  19. Metastatic Gastric Melanoma: A Challenging Diagnosis

    Tumori Journal, 2010

    DOI 10.1177/030089161009600321 PMID 20845816 12 citations (Europe PMC) Source: OpenAlex

  20. Mitochondrial neurogastrointestinal encephalomyopathy: Case report

    The Turkish Journal of Gastroenterology, 2010

    DOI 10.4318/tjg.2010.0106 PMID 20931438 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  21. NONALKOLİK KARACİĞER YAĞLANMASI VE STEATOHEPATİT

    DergiPark (Istanbul University), 2010

    DOI 10.18017/itfd.10884 Source: OpenAlex

  22. Melanoma metastasis to the breast: A diagnostic pitfall

    Cancer Detection and Prevention, 2009

    DOI 10.1016/j.canep.2009.04.001 PMID 19588546 5 citations (Europe PMC) Source: OpenAlex

  23. Üst gastrointestinal endoskopide tanı konan Ascaris lumbricoides olgusu

    DergiPark (Istanbul University), 2009

    DOI 10.17941/agd.76215 Open-access full textSource: OpenAlex

  24. mpaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease.

    Source: acibadem.com.tr profile page